These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 31660973)

  • 61. The impact of viral hepatitis-related hepatocellular carcinoma to post-transplant outcomes.
    Younossi ZM; Stepanova M; Saab S; Ahmed A; Lam B; Srishord M; Venkatesan C; Wai H; Henry L
    J Viral Hepat; 2016 Jan; 23(1):53-61. PubMed ID: 26289820
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Fas / FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease.
    Bortolami M; Kotsafti A; Cardin R; Farinati F
    J Viral Hepat; 2008 Jul; 15(7):515-22. PubMed ID: 18331250
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
    Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
    World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hepatitis B virus gene in liver tissue promotes hepatocellular carcinoma development in chronic hepatitis C patients.
    Fujioka S; Shimomura H; Iwasaki Y; Fujio K; Nakagawa H; Onishi Y; Takagi S; Taniguchi H; Umeoka F; Nakajima H; Moriya A; Nanba K; Piao CY; Shinji T; Koide N; Shiratori Y
    Dig Dis Sci; 2003 Oct; 48(10):1920-4. PubMed ID: 14627334
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
    Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Genome-wide identification of blood DNA methylation patterns associated with early-onset hepatocellular carcinoma development in hepatitis B carriers.
    Kao WY; Yang SH; Liu WJ; Yeh MY; Lin CL; Liu CJ; Huang CJ; Lin SM; Lee SD; Chen PJ; Yu MW
    Mol Carcinog; 2017 Feb; 56(2):425-435. PubMed ID: 27254796
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Association of p16INK4A hypermethylation with hepatitis B virus X protein expression in the early stage of HBV-associated hepatocarcinogenesis.
    Zhu R; Li BZ; Li H; Ling YQ; Hu XQ; Zhai WR; Zhu HG
    Pathol Int; 2007 Jun; 57(6):328-36. PubMed ID: 17539963
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hepatocellular carcinoma in Germany: a retrospective epidemiological study from a low-endemic area.
    Kubicka S; Rudolph KL; Hanke M; Tietze MK; Tillmann HL; Trautwein C; Manns M
    Liver; 2000 Jul; 20(4):312-8. PubMed ID: 10959810
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of occult hepatitis B virus infection on the early-onset of hepatocellular carcinoma in patients with hepatitis C virus infection.
    Nakano M; Kawaguchi T; Nakamoto S; Kawaguchi A; Kanda T; Imazeki F; Kuromatsu R; Sumie S; Satani M; Yamada S; Torimura T; Kakuma T; Yokosuka O; Sata M
    Oncol Rep; 2013 Nov; 30(5):2049-55. PubMed ID: 23982634
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Identification of TAF1, SAT1, and ARHGEF9 as DNA methylation biomarkers for hepatocellular carcinoma.
    Cai C; Xie X; Zhou J; Fang X; Wang F; Wang M
    J Cell Physiol; 2020 Jan; 235(1):611-618. PubMed ID: 31283007
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Association of XRCC1, XRCC3, and XPD genetic polymorphism with an increased risk of hepatocellular carcinoma because of the hepatitis B and C virus.
    Gulnaz A; Sayyed AH; Amin F; Khan Au; Aslam MA; Shaikh RS; Ali M
    Eur J Gastroenterol Hepatol; 2013 Feb; 25(2):166-79. PubMed ID: 23044807
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Gene copy number variations in the leukocyte genome of hepatocellular carcinoma patients with integrated hepatitis B virus DNA.
    Pang Y; Guo W; Wang J; Xu G; Cheng K; Cao G; Wu M; Cheng S; Liu S
    Oncotarget; 2016 Feb; 7(7):8006-18. PubMed ID: 26769853
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Epidemiology of hepatocellular carcinoma in a rural area. Role of hepatotrophic viruses on survival].
    Rodríguez-Vidigal FF; Baz MJ; Romero J; del Puerto M
    An Med Interna; 2005 Apr; 22(4):162-6. PubMed ID: 16004511
    [TBL] [Abstract][Full Text] [Related]  

  • 74. MicroRNA-224 Expression and Polymorphism Predict the Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma Patients After Liver Resection.
    Wu C; Wang X; Zhang J; Tang G; Xu Y; Lu C; Li Y
    Clin Lab; 2019 Jun; 65(6):. PubMed ID: 31232017
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Three Gene Signature for Predicting the Development of Hepatocellular Carcinoma in Chronically Infected Hepatitis C Virus Patients.
    Ibrahim MK; Salama H; Abd El Rahman M; Dawood RM; Bader El Din NG; Salem HF; Abdelrahim ME; Omran D; Omran MH; El-Wakeel KH; Abdelhafez TH; Khedr A; El Awady MK
    J Interferon Cytokine Res; 2016 Dec; 36(12):698-705. PubMed ID: 27726464
    [TBL] [Abstract][Full Text] [Related]  

  • 76. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Improving survival in patients with hepatocellular carcinoma related to chronic hepatitis C and B but not in those related to non-alcoholic steatohepatitis or alcoholic liver disease: a 20-year experience from a national programme.
    Hassan I; Gane E
    Intern Med J; 2019 Nov; 49(11):1405-1411. PubMed ID: 30908822
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Human leukocyte antigen class I alleles and haplotypes associated with primary hepatocellular carcinoma in persistent HBV-infected patients.
    Pan N; Chen K; Qiu J; Sun H; Xu J; Miao F; Shi Q; Jiang W; Jin H; He Y; Xie W; Zhang J
    Hum Immunol; 2013 Jun; 74(6):758-63. PubMed ID: 23459080
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Tumor-suppressor p53 gene in hepatitis C and B virus-associated human hepatocellular carcinoma.
    Shieh YS; Nguyen C; Vocal MV; Chu HW
    Int J Cancer; 1993 Jun; 54(4):558-62. PubMed ID: 8390407
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Proteomic analysis of differentially expressed proteins in hepatitis B virus-related hepatocellular carcinoma tissues.
    Li N; Long Y; Fan X; Liu H; Li C; Chen L; Wang Z
    J Exp Clin Cancer Res; 2009 Aug; 28(1):122. PubMed ID: 19715608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.